INS and type 1 diabetes mellitus: Treatment of T1D patients aims to mimic the physiological glycemic pattern seen in nondiabetic individuals through intensive insulin therapy regimens, which include multiple daily insulin (MDI) administrations or continuous subcutaneous insulin infusion (CSII) systems (1,2).